Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Investigative Dermatology|December 20, 2000
Intracutaneous genetic immunization with autologous melanoma-associated antigen Pmel17/gp100 induces T cell-mediated tumor protection in vivoS N Wagner, C Wagner, P Lührs, et al.
Vox Sanguinis|December 22, 2006
Apheresis products of the Amicus and the AS.TEC 204 cell separators are comparable with regard to dendritic cells derived from the mononuclear cell collectionG C Leitner, F Koszik, T Rudnicki, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccinationG Maass, W Schmidt, M Berger, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1994
Genetic modification of cells by receptor-mediated adenovirus-augmented gene delivery: a new approach for immunotherapy of cancerK Zatloukal, A Schneeberger, M Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parametersK Zatloukal, A Schneeberger, M Berger, et al.
Experimental Dermatology|December 1, 2000
What is the most promising strategy for the treatment of metastasizing melanoma?N Cascinelli, M Heerlyn, A Schneeberger, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
"Time Saved" Calculations to Improve Decision-Making in Progressive Disease StudiesS P Dickson, B Haaland, C H Mallinckrodt, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 1, 1995
Genetic linkage of Wagner disease and erosive vitreoretinopathy to chromosome 5q13-14D M Brown, R A Graemiger, M Hergersberg, et al.
The Journal of Prevention of Alzheimer'S Disease|December 13, 2017
Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's DiseaseA Schneeberger, S Hendrix, M Mandler, et al.
Pageof 3